257 related articles for article (PubMed ID: 26597178)
1. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.
Cox MC; Kusters JM; Gidding CE; Schieving JH; van Lindert EJ; Kaanders JH; Janssens GO
Radiat Oncol; 2015 Nov; 10():241. PubMed ID: 26597178
[TBL] [Abstract][Full Text] [Related]
2. Optimal normal tissue sparing in craniospinal axis irradiation using IMRT with daily intrafractionally modulated junction(s).
Kusters JM; Louwe RJ; van Kollenburg PG; Kunze-Busch MC; Gidding CE; van Lindert EJ; Kaanders JH; Janssens GO
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1405-14. PubMed ID: 21300472
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Craniospinal Irradiation for Pediatric Medulloblastoma Using VMAT and IMRT.
Al-Wassia RK; Ghassal NM; Naga A; Awad NA; Bahadur YA; Constantinescu C
J Pediatr Hematol Oncol; 2015 Oct; 37(7):e405-11. PubMed ID: 26334433
[TBL] [Abstract][Full Text] [Related]
4. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
[TBL] [Abstract][Full Text] [Related]
5. Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.
Kumar N; Miriyala R; Thakur P; Madan R; Salunke P; Yadav B; Gupta A
J Neurooncol; 2017 Sep; 134(2):309-315. PubMed ID: 28577033
[TBL] [Abstract][Full Text] [Related]
6. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
7. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
8. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
[TBL] [Abstract][Full Text] [Related]
10. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
[TBL] [Abstract][Full Text] [Related]
11. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
[TBL] [Abstract][Full Text] [Related]
12. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.
Paulino AC; Mazloom A; Teh BS; South M; Okcu MF; Su J; Butler EB; Chintagumpala M
Cancer; 2011 Feb; 117(3):635-41. PubMed ID: 20845476
[TBL] [Abstract][Full Text] [Related]
13. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
[TBL] [Abstract][Full Text] [Related]
14. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.
Lopez Guerra JL; Marrone I; Jaen J; Bruna M; Sole C; Sanchez-Reyes A; Rivin E; Ortiz MJ; Calvo F; Matute R
Clin Transl Oncol; 2014 Jan; 16(1):96-101. PubMed ID: 23632814
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a new noncoplanar intensity-modulated radiation therapy technique for craniospinal irradiation with 3 coplanar techniques.
Hansen AT; Lukacova S; Lassen-Ramshad Y; Petersen JB
Med Dosim; 2015; 40(4):296-303. PubMed ID: 26002123
[TBL] [Abstract][Full Text] [Related]
16. Effect of prophylactic granulocyte-colony stimulating factor (G-CSF) on acute hematological toxicity in medulloblastoma patients during craniospinal irradiation (CSI).
Madan R; Kumar N; Gupta A; Gupta K; Salunke P; Khosla D; Yadav BS; Kapoor R
Clin Neurol Neurosurg; 2020 Sep; 196():105975. PubMed ID: 32505868
[TBL] [Abstract][Full Text] [Related]
17. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks.
Parker W; Filion E; Roberge D; Freeman CR
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):251-7. PubMed ID: 17707279
[TBL] [Abstract][Full Text] [Related]
19. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]